Measurement of Markers of Tobacco Smoking in Patients with Coronary Heart Disease
Author(s) -
G P R Archbold,
Margaret Cupples,
A McKnight,
T. Linton
Publication year - 1995
Publication title -
annals of clinical biochemistry international journal of laboratory medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.6
H-Index - 80
eISSN - 1758-1001
pISSN - 0004-5632
DOI - 10.1177/000456329503200213
Subject(s) - medicine , coronary heart disease , nicotine , smoking cessation , metabolite , tobacco use , smoking history , cotinine , passive smoking , tobacco smoke , risk factor , urinary system , disease , environmental health , pathology , population
591 patients with a history of coronary heart disease had one or more biochemical markers of tobacco smoking measured. 26% were self reported smokers and a further 4% were apparent ‘smoking deceivers’. The urinary nicotine metabolite concentration is an excellent marker for tobacco smoking; breath CO would be a suitable alternative for busy clinics. Half the patients were subjected to regular advice on risk factor management but there was no evidence that this contributed effectively to smoking cessation. Overall smoking cessation rate was poor.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom